Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - SHORT-TERM DEBT
Short-term Debt SGMO - Sangamo Therapeutics, Inc.
4.59 M
LAST VALUE
6.76%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR